Transcriptional regulation of the human prolactin gene;REGULATION TRANSCRIPTIONNELLE DU GENE DE LA PROLACTINE HUMAINE

Medecine/Sciences

Volumn 14, Issue 5, 1998, Pages 580-587

  Muller, Marc ^a,b   Berwaer, Monique ^d   Caccavelli, Laure ^c   Manfroid, Isabelle ^b   Nalda, Asuncion ^e   Pendeville, Hélène ^f   Pernasetti, Flavia ^g   Van De Weerdt, Cécile ^b   Peers, Bernard ^a,b   Martial, Joseph A ^b  

^a FNRS ^*

^b UNIVERSITY OF LIÈGE   (Belgium)

^c HÔPITAL BROUSSAIS   (France)

^d ASTRAZENECA   (United Kingdom)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CYCLIC AMP; DOPAMINE; ESTROGEN RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE; PROLACTIN; PROTEIN KINASE; PROTIRELIN; STEROID; THYROID HORMONE; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR PIT 1;

ADENOHYPOPHYSIS; BINDING SITE; GENE EXPRESSION; HUMAN; PROMOTER REGION; RECEPTOR BINDING; REGULATOR GENE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 13144293106     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1096     Document Type: Review

References (41)

1. Coffin V, Shiverick KT, Kelly PA, Martial JA. Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr Rev 1996; 17: 385-410.
2. Cooke NE, Coit D, Shine J. Baxter JD, Martial JA. Human prolactin. cDNA structural analysis and evolutionary comparisons. J Biol Chem 1981; 256: 4007-16.
3. Nicoll CS. Physiological actions of prolactin. In: Knobil E, Sawyer WH, eds. Handbook of Physiology, vol. 4. Washington DC: American Physiological Society, 1974; 4: 253-92.
4. Flint DJ, Gardner M. Evidence that growth hormone stimulates milk synthesis by direct action on the mammary gland and that prolactin exerts effects on milk secretion by maintenance of mammary deoxvribonucleic acid content and tight junction status. Endocrinology 1994; 135: 1119-24.
5. Gala RR. Prolactin and growth hormone in the regulation of the immune system. Proc Soc Exp Biol Med 1991; 198: 513-27.
6. Koller M, Kotzmann H, Clodi M, Riedl M, Luger A. Effect of elevated serum prolactin concentrations on the immunophenotype of human lymphocytes, mitogen-induced proliferation and phagocytic activity of polymorphonuclear cells. Eur J Clin Invest 1997; 27: 662-6.
7. Mukherjee P, Mastro AM, Hymer WC. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology 1990; 126: 88-94.
8. Gala RR, Shevach EM. Influence of prolactin and growth hormone on the activation of dwarf mice lymphocytes in vivo. Proc Soc Exp Biol Med 1993; 204: 224-30.
9. Berton E, Meltzer WMS, Holaday JW. Suppression of macrophage activation and T-lymphocytes function in hypoprolactinemic mice. Science 1988; 239: 401-4.
10. de Vlaming VL. Actions of prolactin among vertebrates. In: Knobil E, Sawyer WH, eds. Hormones and evolution. New York: Academic Press, 1979: 561-642.
11. Emanuele NV, Jurgens JK, Halloran MM, Tender JJ, Lawrence AM, Kelley MR. The rat prolactin gene is expressed in brain tissue: detection of normal and alternative spliced prolactin messenger RNA. J Endocrinol 1992; 136: 271-6.
12. Pellegrini I, Lebrun JJ, Kelly PA. Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 1992; 6: 1023-31.
13. Wu WX, Brooks J, Millar MR, Ledger WL, Saunders PTK, Glasier AF, McNeilly AS. Localization of the sites of synthesis and action of prolactin by immunocytochemistry and in situ hybridization within the utero-pla-cental unit. J Mol Endocrinol 1991; 7: 241-7.
14. Steinmetz RW, Grant AL, Malven PV. Transcription of the prolactin gene in milk secretory cells of the rat mammary gland. J Endocrinol 1993; 136: 271-6.
15. Elsholtz HP, Lew AM, Albert PR, Sundmark VC. Inhibitory control of prolactin and Pit-1 gene promoters by dopamine. Dual signaling pathways required for D2 receptor-regulated expression of the prolactin gene, J Biol Chem 1991; 266: 22919-25.
16. Berwaer M, Monget P, Peers B, Mathy-Hartert M, Bellefroid E, Davis JR, Belayew A, Martial JA. Multihormonal regulation of the human prolactin gene expression from 5 000 bp of its upstream sequence, Mol Cell Endocrinol 1991; 80: 53-64.
17. Berwaer M, Peers B, Nalda AM, Monget P, Davis JR, Belayew A, Martial JA. Thyrotropin-releasing hormone and epidermal growth factor induce human prolactin expression via identical multiple cis elements. Mol Cell Endomnol 1993; 92: 1-7.
18. Scully KM, Gleiberman AS, Lindzey J, Lubahn DB, Korach KS, Rosenfeld MG. Role of estrogen receptor-alpha in the anterior pituitary gland. Mol Endocrinol 1997; 11: 674-81.
19. Nalda AM, Martial JA, Muller M. The glucocorticoid receptor inhibits the human prolactin gene transcription by interference with Pit-1 activity. Mol Cell Endocrinol 1997; 164: 129-37.
20. Pernasetti F, Caccavelli L, Van de Weerdt C, Martial JA, Muller M. Thyroid hormone inhibits the human prolactin gene promoter by interfering with activating protein-1 and estrogen stimulations. Mol Endocrinol 1997; 11: 986-96.
21. Truong AT, Duez C, Belayew A, Renard A, Pictet R, Bell GI, Martial JA. Isolation and characterization of the human prolactin gene. EMBO J 1984; 3: 429-37.
22. Peers B, Voz ML, Monget P, Mathy-Hartert M, Berwaer M, Belayew A, Martial JA. Regulatory elements controlling pituitary-specific expression of the human prolactin gene. Mol Cell Biol 1990; 10: 4690-700.
23. He X, Treacy MN, Simmons DM, Ingraham HA, Swanson LW, Rosenfeld MG. Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 1989; 340: 35-41.
24. Theill LE, Karin M. Transcriptional control of GH expression and anterior pituitary development. Endocr Rev 1993; 14: 670-89.
25. Bradford AP, Wasylyk C, Wasylyk B, Gutierrez-Hartmann A. Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression. Mol Cell Biol 1997; 17: 1065-74.
26. Szeto DP, Ryan AK, O'Connell SM, Rosenfeld MG. P-OTX: a PIT-1-interacting homeodomain factor expressed during anterior pituitary gland development. Proc Natl Acad Sci USA 1996; 93: 7706-10.
27. Ohta K, Nobukuni Y, Mitsubuchi H, Ohta T, Tohma T, Jinno Y, Endo F, Matsuda I. Characterization of the gene encoding human pituitary-specific transcription factor, Pit-1. Gene 1902; 122: 387-8.
28. de Zegher F, Pernasetti F, Vanhole C, Devlieger H, Van den Berghe G, Martial JA. The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency. J Clin Endocrinol Metab 1995; 80: 3127-30.
29. Laverriere JN, Richard JL, Buisson N, Martial JA, Tixier-Vidal A, Gourdji D. Thyroliberin and dihydropyridines modulate prolactin gene expression through interacting pathways in GH3 cells. Neuroendocrinology 1989; 50: 693-701.
30. Hoggard N, Davis JR, Berwaer M, Monget P, Peers B, Belayew A, Martial JA. Pit-1 binding sequences permit calcium regulation of human prolactin gene expression. Mol Endocrinol 1991; 5: 1748-54.
31. Peers B, Nalda AM, Monget P, Voz ML, Belayew A, Martial JA. Binding of a 100-kDa ubiquitous factor to the human prolactin promoter is required for its basal and hormone-regulatea activity. Eur J Biochem 1992; 210: 53-8
32. Wera S, Belayew A, Martial JA. Okadaic acid, a protein phosphatase inhibitor, enhances transcription of a receptor gene containing sequence A of the human prolactin promoter. Mol Endocrinol 1993; 7: 965-71.
33. De Camilli P, Macconi D, Spada A. Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas. Nature 1979; 278: 252-4.
34. Onali P, Eva C, Olivias MC, et al. In GH3 cells, acetylcholine and VIP antagonistically modulate adenylate cyclase, cyclic AMP content and PRL secretion. Mol Pharmacol 1983; 24: 189-94.
35. Peers B, Monget P, Nalda MA, Voz ML, Berwaer M, Belayew A, Martial JA. Transcriptional induction of the human prolactin gene by cAMP requires two cis-acting elements and at least the pituitary-specific factor Pit-1. J Biol Chem 1991; 266: 18127-34.
36. Wera S, Belayew A, Martial JA. Rapamycin, FK506 and cyclosporin A inhibit human prolactin gene expression. FEBS Lett 1995; 358: 158-60.
37. Sabharwal P, Glaser R, Lafuse W, Varma S, Liu Q, Arkins S, Kooijman R, Kutz L, Kelley KW, Malarkey WB. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proc Natl Acad Sci USA 1992; 89: 7713-6.
38. DiMattia GE, Gellersen B, Duckworth ML, Friesen HG. Human prolactin gene expression. The use of an alternative noncoding exon in decidua and the IM-9-P3 lymphoblast cell line. J Biol Chem 1990; 265: 16412-21.
39. Gellersen B, Kempf R, Telgmann R, DiMattia GE. Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol 1994; 8: 356-73.
40. Berwaer M, Martial JA, Davis JR. Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene. Mol Endocrinol 1994; 8: 635-42.
41. Delhase M, Vergani P, Malur A, Hooghe-Peters EL, Hooghe RJ. The transcription factor Pit-1/GHF-1 is expressed in hemopoietic and lymphoid tissues. Eur J Immunol 1993; 23: 951-5.